SCHEMBL26683140

SCHEMBL26683140

CCOc1cc(C=O)cc(-c2cncc(O)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 5/20 0.39
▸ CYP11B2 P19099 5/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ ERN1 O75460 1/20 0.37
▸ HSD17B1 P14061 1/20 0.37
▸ CHRNB2 P17787 1/20 0.36
▸ CHRNB4 P30926 1/20 0.36
▸ CHRNA3 P32297 1/20 0.36
▸ CHRNA7 P36544 1/20 0.36
▸ CHRNA4 P43681 1/20 0.36
▸ PIK3CG P48736 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ FYN P06241 1/20 0.35
▸ CYP1A1 P04798 1/20 0.35
▸ CYP1B1 Q16678 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30687719 1.00 CYP11B1 (0.39) CYP11B1CYP11B2KDM4EALDH1A1ERN1
SCHEMBL26681990 0.81 ALDH1A3 (0.41) CYP11B1CYP11B2ERN1HSD17B1CHRNB2
SCHEMBL26683072 0.80 RXRA (0.45) KDM4EALDH1A1ERN1HSD17B1SMN1; SMN2
SCHEMBL26682888 0.78 PIP4K2A (0.38) CYP11B1CYP11B2ERN1HSD17B1CYP1A1
SCHEMBL1621388 0.77 ALDH1A1 (0.50) KDM4EALDH1A1ERN1SMN1; SMN2
SCHEMBL16180169 0.74 CYP11B1 (0.52) CYP11B1CYP11B2KDM4EALDH1A1CHRNB2
SCHEMBL18002510 0.74 RXRA (0.47) KDM4EALDH1A1ERN1SMN1; SMN2PTGS2
SCHEMBL5883815 0.74 ALDH1A1 (0.47) KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL273282 0.74 ALDH1A1 (0.47) KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL3884124 0.73 CHRNB2 (0.55) CYP11B1CYP11B2KDM4EALDH1A1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-04-25 — — US disclosed
EP-4279476-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-11-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240132431-A1 METHOD FOR ALKYLATING ACIDIC FUNCTIONAL GROUP MGMT, MCL1, FANCF CYP11B1 373/4885CYP11B2 347/4885KDM4E 1910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback